Proteasome inhibitors induce mitochondria-independent apoptosis in human glioma cells

The proteasome inhibitors lactacystin and AcLLNal induced p53-independent apoptosis in two human glioma cell lines, and the apoptosis was accompanied by up-regulation of immunoreactive wild-type p53, p21 Waf1, Mdm2, and p27 Kip1. Pretreatment with cycloheximide decreased the induction of cell death...

Full description

Saved in:
Bibliographic Details
Published in:FEBS letters Vol. 443; no. 2; pp. 181 - 186
Main Authors: Kitagawa, Hiroyuki, Tani, Eiichi, Ikemoto, Hideyasu, Ozaki, Isao, Nakano, Atsuhisa, Omura, Satoshi
Format: Journal Article
Language:English
Published: England Elsevier B.V 29-01-1999
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The proteasome inhibitors lactacystin and AcLLNal induced p53-independent apoptosis in two human glioma cell lines, and the apoptosis was accompanied by up-regulation of immunoreactive wild-type p53, p21 Waf1, Mdm2, and p27 Kip1. Pretreatment with cycloheximide decreased the induction of cell death independently of p53 protein status, suggesting that the up-regulation of short-lived proteins is associated with proteasome inhibitor-induced apoptosis. Caspase-3-like proteases were activated in the proteasome inhibitor-mediated apoptosis, and the induction of cell death was inhibited more effectively in the presence of z-VAD.fmk than in the presence of Ac-DEVD.fmk, suggesting that caspases other than caspase-3 are involved. Nonetheless, there were no significant alterations in levels of immunoreactive Bcl-2, Bcl-x L, Bax, Bad, and Bak, nor any evidence of cytochrome c release into cytosol and dissipation of Δ Ψ m. Thus, the proteasome inhibitor-induced apoptosis is mediated by a mitochondria-independent mechanism, and the once activated caspase-3 does not cause the cytochrome c release and the Δ Ψ m disruption.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0014-5793
1873-3468
DOI:10.1016/S0014-5793(98)01709-8